O	0	12	Angiogenesis	Angiogenesis	NN	B-NP
O	13	15	in	in	IN	B-PP
O	16	24	platelet	platelet	NN	B-NP
O	25	36	endothelial	endothelial	JJ	I-NP
O	37	41	cell	cell	NN	I-NP
O	42	50	adhesion	adhesion	NN	I-NP
O	51	59	molecule	molecule	NN	I-NP
O	59	60	-	-	HYPH	B-NP
O	60	61	1	1	CD	I-NP
O	61	62	-	-	HYPH	I-NP
O	62	66	null	null	JJ	I-NP
O	67	71	mice	mouse	NNS	I-NP
O	71	72	.	.	.	O

O	73	81	Platelet	Platelet	NN	B-NP
O	82	93	endothelial	endothelial	JJ	I-NP
O	94	98	cell	cell	NN	I-NP
O	99	107	adhesion	adhesion	NN	I-NP
O	108	116	molecule	molecule	NN	I-NP
O	117	118	(	(	(	O
O	118	123	PECAM	PECAM	NN	B-NP
O	123	124	)	)	)	O
O	124	125	-	-	HYPH	B-NP
O	125	126	1	1	CD	I-NP
O	127	130	has	have	VBZ	B-VP
O	131	135	been	be	VBN	I-VP
O	136	146	previously	previously	RB	I-VP
O	147	157	implicated	implicate	VBN	I-VP
O	158	160	in	in	IN	B-PP
B-Cell	161	172	endothelial	endothelial	JJ	B-NP
I-Cell	173	177	cell	cell	NN	I-NP
O	178	187	migration	migration	NN	I-NP
O	187	188	;	;	:	O
O	189	201	additionally	additionally	RB	B-ADVP
O	201	202	,	,	,	O
O	203	207	anti	anti	AFX	O
O	207	208	-	-	HYPH	B-NP
O	208	213	PECAM	PECAM	NN	I-NP
O	213	214	-	-	HYPH	B-NP
O	214	215	1	1	CD	I-NP
O	216	226	antibodies	antibody	NNS	I-NP
O	227	231	have	have	VBP	B-VP
O	232	236	been	be	VBN	I-VP
O	237	242	shown	show	VBN	I-VP
O	243	245	to	to	TO	I-VP
O	246	253	inhibit	inhibit	VB	I-VP
O	254	256	in	in	FW	B-NP
O	257	261	vivo	vivo	FW	I-NP
O	262	274	angiogenesis	angiogenesis	NN	I-NP
O	274	275	.	.	.	O

O	276	283	Studies	Study	NNS	B-NP
O	284	288	were	be	VBD	B-VP
O	289	298	therefore	therefore	RB	I-VP
O	299	308	performed	perform	VBN	I-VP
O	309	313	with	with	IN	B-PP
O	314	319	PECAM	PECAM	NN	B-NP
O	319	320	-	-	HYPH	B-NP
O	320	321	1	1	CD	I-NP
O	321	322	-	-	HYPH	I-NP
O	322	326	null	null	JJ	I-NP
O	327	331	mice	mouse	NNS	I-NP
O	332	334	to	to	TO	B-VP
O	335	342	further	further	RB	I-VP
O	343	349	define	define	VB	I-VP
O	350	353	the	the	DT	B-NP
O	354	365	involvement	involvement	NN	I-NP
O	366	368	of	of	IN	B-PP
O	369	374	PECAM	PECAM	NN	B-NP
O	374	375	-	-	HYPH	B-NP
O	375	376	1	1	CD	I-NP
O	377	379	in	in	IN	B-PP
B-Multi-tissue_structure	380	385	blood	blood	NN	B-NP
I-Multi-tissue_structure	386	392	vessel	vessel	NN	I-NP
O	393	402	formation	formation	NN	I-NP
O	402	403	.	.	.	O

O	404	419	Vascularization	Vascularization	NN	B-NP
O	420	422	of	of	IN	B-PP
B-Immaterial_anatomical_entity	423	435	subcutaneous	subcutaneous	JJ	B-NP
O	436	444	Matrigel	Matrigel	NNP	I-NP
O	445	453	implants	implant	NNS	I-NP
O	454	456	as	as	RB	B-CONJP
O	457	461	well	well	RB	I-CONJP
O	462	464	as	as	IN	I-CONJP
B-Cancer	465	470	tumor	tumor	NN	B-NP
O	471	483	angiogenesis	angiogenesis	NN	I-NP
O	484	488	were	be	VBD	B-VP
O	489	493	both	both	DT	O
O	494	503	inhibited	inhibit	VBN	B-VP
O	504	506	in	in	IN	B-PP
O	507	512	PECAM	PECAM	NN	B-NP
O	512	513	-	-	HYPH	B-NP
O	513	514	1	1	CD	I-NP
O	514	515	-	-	HYPH	I-NP
O	515	519	null	null	JJ	I-NP
O	520	524	mice	mouse	NNS	I-NP
O	524	525	.	.	.	O

O	526	536	Reciprocal	Reciprocal	JJ	B-NP
B-Multi-tissue_structure	537	541	bone	bone	NN	I-NP
I-Multi-tissue_structure	542	548	marrow	marrow	NN	I-NP
O	549	560	transplants	transplant	NNS	I-NP
O	561	565	that	that	WDT	B-NP
O	566	574	involved	involve	VBD	B-VP
O	575	579	both	both	CC	O
O	580	584	wild	wild	JJ	B-NP
O	584	585	-	-	HYPH	I-NP
O	585	589	type	type	NN	I-NP
O	590	593	and	and	CC	I-NP
O	594	599	PECAM	PECAM	NN	I-NP
O	599	600	-	-	HYPH	B-NP
O	600	601	1	1	CD	I-NP
O	601	602	-	-	HYPH	I-NP
O	602	611	deficient	deficient	JJ	I-NP
O	612	616	mice	mouse	NNS	I-NP
O	617	625	revealed	reveal	VBD	B-VP
O	626	630	that	that	IN	B-SBAR
O	631	634	the	the	DT	B-NP
O	635	643	impaired	impaired	JJ	I-NP
O	644	654	angiogenic	angiogenic	JJ	I-NP
O	655	663	response	response	NN	I-NP
O	664	672	resulted	result	VBD	B-VP
O	673	677	from	from	IN	B-PP
O	678	679	a	a	DT	B-NP
O	680	684	loss	loss	NN	I-NP
O	685	687	of	of	IN	B-PP
B-Cell	688	699	endothelial	endothelial	JJ	B-NP
O	699	700	,	,	,	I-NP
O	701	704	but	but	CC	I-NP
O	705	708	not	not	RB	I-NP
B-Cell	709	718	leukocyte	leukocyte	NN	B-NP
O	718	719	,	,	,	O
O	720	725	PECAM	PECAM	NN	B-NP
O	725	726	-	-	HYPH	B-NP
O	726	727	1	1	CD	I-NP
O	727	728	.	.	.	O

O	729	731	In	In	FW	B-NP
O	732	737	vitro	vitro	FW	I-NP
B-Pathological_formation	738	743	wound	wound	NN	I-NP
O	744	753	migration	migration	NN	I-NP
O	754	757	and	and	CC	O
O	758	764	single	single	JJ	B-NP
O	764	765	-	-	HYPH	I-NP
B-Cell	765	769	cell	cell	NN	I-NP
O	770	778	motility	motility	NN	I-NP
O	779	781	by	by	IN	B-PP
B-Cell	782	787	PECAM	PECAM	NN	B-NP
I-Cell	787	788	-	-	HYPH	B-NP
I-Cell	788	789	1	1	CD	I-NP
I-Cell	789	790	-	-	HYPH	I-NP
I-Cell	790	794	null	null	JJ	I-NP
I-Cell	795	806	endothelial	endothelial	JJ	I-NP
I-Cell	807	812	cells	cell	NNS	I-NP
O	813	817	were	be	VBD	B-VP
O	818	822	also	also	RB	I-VP
O	823	834	compromised	compromise	VBN	I-VP
O	834	835	.	.	.	O

O	836	838	In	In	IN	B-PP
O	839	847	addition	addition	NN	B-NP
O	847	848	,	,	,	O
B-Cellular_component	849	858	filopodia	filopodia	NN	B-NP
O	859	868	formation	formation	NN	I-NP
O	868	869	,	,	,	O
O	870	871	a	a	DT	B-NP
O	872	879	feature	feature	NN	I-NP
O	880	882	of	of	IN	B-PP
O	883	889	motile	motile	NN	B-NP
B-Cell	890	895	cells	cell	NNS	I-NP
O	895	896	,	,	,	O
O	897	900	was	be	VBD	B-VP
O	901	910	inhibited	inhibit	VBN	I-VP
O	911	913	in	in	IN	B-PP
B-Cell	914	919	PECAM	PECAM	NN	B-NP
I-Cell	919	920	-	-	HYPH	B-NP
I-Cell	920	921	1	1	CD	I-NP
I-Cell	921	922	-	-	HYPH	I-NP
I-Cell	922	926	null	null	JJ	I-NP
I-Cell	927	938	endothelial	endothelial	JJ	I-NP
I-Cell	939	944	cells	cell	NNS	I-NP
O	945	947	as	as	RB	B-CONJP
O	948	952	well	well	RB	I-CONJP
O	953	955	as	as	IN	I-CONJP
O	956	958	in	in	IN	B-PP
O	959	964	human	human	JJ	B-NP
B-Cell	965	976	endothelial	endothelial	JJ	I-NP
I-Cell	977	982	cells	cell	NNS	I-NP
O	983	990	treated	treat	VBN	B-VP
O	991	995	with	with	IN	B-PP
O	996	1002	either	either	CC	O
O	1003	1007	anti	anti	AFX	O
O	1007	1008	-	-	HYPH	B-NP
O	1008	1013	PECAM	PECAM	NN	I-NP
O	1013	1014	-	-	HYPH	B-NP
O	1014	1015	1	1	CD	I-NP
O	1016	1024	antibody	antibody	NN	I-NP
O	1025	1027	or	or	CC	I-NP
O	1028	1033	PECAM	PECAM	NN	I-NP
O	1033	1034	-	-	HYPH	B-NP
O	1034	1035	1	1	CD	I-NP
O	1036	1041	siRNA	siRNA	NN	I-NP
O	1041	1042	.	.	.	O

O	1043	1054	Furthermore	Furthermore	RB	B-ADVP
O	1054	1055	,	,	,	O
O	1056	1059	the	the	DT	B-NP
O	1060	1070	expression	expression	NN	I-NP
O	1071	1073	of	of	IN	B-PP
O	1074	1079	PECAM	PECAM	NN	B-NP
O	1079	1080	-	-	HYPH	B-NP
O	1080	1081	1	1	CD	I-NP
O	1082	1090	promoted	promote	VBD	B-VP
B-Cellular_component	1091	1100	filopodia	filopodia	NN	B-NP
O	1101	1110	formation	formation	NN	I-NP
O	1111	1114	and	and	CC	O
O	1115	1124	increased	increase	VBD	B-VP
O	1125	1128	the	the	DT	B-NP
O	1129	1136	protein	protein	NN	I-NP
O	1137	1147	expression	expression	NN	I-NP
O	1148	1154	levels	level	NNS	I-NP
O	1155	1157	of	of	IN	B-PP
O	1158	1163	Cdc42	Cdc42	NN	B-NP
O	1163	1164	,	,	,	O
O	1165	1166	a	a	DT	B-NP
O	1167	1170	Rho	Rho	NN	I-NP
O	1171	1177	GTPase	GTPase	NN	I-NP
O	1178	1182	that	that	WDT	B-NP
O	1183	1185	is	be	VBZ	B-VP
O	1186	1191	known	know	VBN	I-VP
O	1192	1194	to	to	TO	B-VP
O	1195	1202	promote	promote	VB	I-VP
O	1203	1206	the	the	DT	B-NP
O	1207	1216	formation	formation	NN	I-NP
O	1217	1219	of	of	IN	B-PP
B-Cellular_component	1220	1229	filopodia	filopodia	NN	B-NP
O	1229	1230	.	.	.	O

O	1231	1233	In	In	IN	B-PP
O	1234	1237	the	the	DT	B-NP
O	1238	1248	developing	develop	VBG	I-NP
B-Multi-tissue_structure	1249	1256	retinal	retinal	NN	I-NP
I-Multi-tissue_structure	1257	1268	vasculature	vasculature	NN	I-NP
O	1268	1269	,	,	,	O
O	1270	1278	numerous	numerous	JJ	B-NP
O	1278	1279	,	,	,	I-NP
B-Cellular_component	1280	1284	long	long	JJ	I-NP
I-Cellular_component	1285	1296	filamentous	filamentous	JJ	I-NP
I-Cellular_component	1297	1306	filopodia	filopodia	NN	I-NP
O	1306	1307	,	,	,	O
O	1308	1317	emanating	emanate	VBG	B-VP
O	1318	1322	from	from	IN	B-PP
B-Cell	1323	1334	endothelial	endothelial	JJ	B-NP
I-Cell	1335	1340	cells	cell	NNS	I-NP
O	1341	1343	at	at	IN	B-PP
O	1344	1347	the	the	DT	B-NP
O	1348	1352	tips	tip	NNS	I-NP
O	1353	1355	of	of	IN	B-PP
O	1356	1366	angiogenic	angiogenic	JJ	B-NP
B-Tissue	1367	1374	sprouts	sprout	NNS	I-NP
O	1374	1375	,	,	,	O
O	1376	1380	were	be	VBD	B-VP
O	1381	1389	observed	observe	VBN	I-VP
O	1390	1392	in	in	IN	B-PP
O	1393	1397	wild	wild	JJ	B-NP
O	1397	1398	-	-	HYPH	I-NP
O	1398	1402	type	type	NN	I-NP
O	1403	1410	animals	animal	NNS	I-NP
O	1410	1411	,	,	,	O
O	1412	1415	but	but	CC	O
O	1416	1418	to	to	TO	B-PP
O	1419	1420	a	a	DT	B-NP
O	1421	1427	lesser	less	JJR	I-NP
O	1428	1434	extent	extent	NN	I-NP
O	1435	1437	in	in	IN	B-PP
O	1438	1441	the	the	DT	B-NP
O	1442	1447	PECAM	PECAM	NN	I-NP
O	1447	1448	-	-	HYPH	B-NP
O	1448	1449	1	1	CD	I-NP
O	1449	1450	-	-	HYPH	I-NP
O	1450	1454	null	null	JJ	I-NP
O	1455	1459	mice	mouse	NNS	I-NP
O	1459	1460	.	.	.	O

O	1461	1469	Together	Together	RB	B-ADVP
O	1469	1470	,	,	,	O
O	1471	1476	these	these	DT	B-NP
O	1477	1481	data	datum	NNS	I-NP
O	1482	1489	further	further	RBR	B-VP
O	1490	1499	establish	establish	VB	I-VP
O	1500	1503	the	the	DT	B-NP
O	1504	1515	involvement	involvement	NN	I-NP
O	1516	1518	of	of	IN	B-PP
B-Cell	1519	1530	endothelial	endothelial	JJ	B-NP
O	1531	1536	PECAM	PECAM	NN	I-NP
O	1536	1537	-	-	HYPH	B-NP
O	1537	1538	1	1	CD	I-NP
O	1539	1541	in	in	IN	B-PP
O	1542	1554	angiogenesis	angiogenesis	NN	B-NP
O	1555	1558	and	and	CC	O
O	1559	1566	suggest	suggest	VBP	B-VP
O	1567	1571	that	that	IN	B-SBAR
O	1571	1572	,	,	,	O
O	1573	1575	in	in	FW	B-ADVP
O	1576	1580	vivo	vivo	FW	I-ADVP
O	1580	1581	,	,	,	O
O	1582	1587	PECAM	PECAM	NN	B-NP
O	1587	1588	-	-	HYPH	B-NP
O	1588	1589	1	1	CD	I-NP
O	1590	1593	may	may	MD	B-VP
O	1594	1603	stimulate	stimulate	VB	I-VP
B-Cell	1604	1615	endothelial	endothelial	JJ	B-NP
I-Cell	1616	1620	cell	cell	NN	I-NP
O	1621	1629	motility	motility	NN	I-NP
O	1630	1632	by	by	IN	B-PP
O	1633	1642	promoting	promote	VBG	B-VP
O	1643	1646	the	the	DT	B-NP
O	1647	1656	formation	formation	NN	I-NP
O	1657	1659	of	of	IN	B-PP
B-Cellular_component	1660	1669	filopodia	filopodia	NN	B-NP
O	1669	1670	.	.	.	O

